ACYCLOVIR
NDC 59651-493, ACYCLOVIR, suspension, from Aurobindo Pharma Limited.
- Product NDC
- 59651-493
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216331
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-493 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACYCLOVIR200 mg/5mL
Pharmacologic classes
DNA Polymerase Inhibitors [MoA]; Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Nucleoside Analog [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-493-47 | 59651049347 | 473 mL in 1 BOTTLE (59651-493-47) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/37761c4f-4378-472e-a41b-6a1d40575cb7
Use it
Look up 59651-493 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-493 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-493. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.